Thursday, November 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Truist Securities Analyst Maintains Hold Rating on James River Group Holdings with Lowered Price Target

Elaine Mendonca by Elaine Mendonca
March 1, 2024
in Breaking News
0
Finances
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

Truist Securities analyst Mark Hughes has decided to maintain a Hold rating on James River Group Holdings (NASDAQ: JRVR) but has made the bold move of lowering the price target from $15 to $11. This decision comes after Truist Financial also decided to decrease their price objective on James River Group from $15 to $11 while keeping a “hold” rating on the stock. The recent downgrade by Truist Securities is just one in a series of adjustments to the price target for James River Group, with analysts giving various reasons for the change. Despite these modifications, the average price target for James River Group Holdings Ltd still stands at $23.60, suggesting a potential 60.00% increase from the current price of $14.75.

JRVR Stock Price Drops 3.66% in Regular Trading Hours, Sees Uptick in After-Hours Trading

On March 1, 2024, JRVR stock experienced a significant drop in price, closing at $9.99, which represented a decrease of $0.38 or 3.66% from the previous market close. Despite the drop in price during regular trading hours, JRVR saw a slight uptick in after-hours trading, with the stock rising $0.49. This after-hours movement may indicate some level of investor confidence in the stock, potentially signaling a reversal in the downward trend that JRVR has been experiencing. Investors should conduct thorough research and consider their own risk tolerance before making any investment decisions. It is recommended to consult with a financial advisor or investment professional for personalized guidance tailored to individual financial goals and circumstances. Stay informed and stay vigilant in monitoring the performance of JRVR and other investments.

JRVR Stock Performance on March 1, 2024: Total Revenue Flat, Net Income Decline, and Earnings per Share Decrease

On March 1, 2024, JRVR stock experienced a mixed performance based on the financial data provided by CNN Money. The total revenue for the company was reported at $812.01 million for the past year, which remained flat compared to the previous year. However, there was a significant decrease of 6.56% in total revenue when compared to the last quarter, which was reported at $218.10 million.

The net income for JRVR was reported at -$107.68 million for the past year, showing a decrease of 447.67% compared to the previous year. On the other hand, the net income held flat since the last quarter, with a reported figure of $20.06 million. This indicates that the company was able to maintain its profitability in the short term despite the significant decrease in net income over the past year.

Earnings per share (EPS) for JRVR were reported at -$3.14 for the past year, showing a decrease of 632.29% compared to the previous year. The EPS further decreased by 1006.64% since the last quarter, with a reported figure of -$4.06. This indicates a significant decline in earnings per share for the company over both the short and long term.

Overall, the financial performance of JRVR on March 1, 2024, reflects a mixed picture. While the company was able to maintain its total revenue and net income in the short term, there were significant declines in both metrics over the past year. The decrease in earnings per share further highlights the challenges faced by JRVR in terms of profitability and financial performance. Investors and analysts will be closely monitoring the company’s future financial reports to assess its ability to improve its financial performance and drive growth in the coming quarters.

Tags: JRVR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Textile sustainable

Breaking Down the Environmental Impact of Clothing Production: What You Need to Know

Food Retailers Stock Bull Market

Analyst Sentiment and Price Targets Point to Bullish Outlook for Bath Body Works

Healthcare-IT-and-tech

TD Cowen Analyst Maintains Outperform Rating on Privia Health Group with Revised Price Target

Recommended

EEFT stock news

Analyst Ratings and Price Targets for Definitive Healthcare

2 years ago
Healthcare Services Stock Exchange

Analyst Ratings and Price Targets for Inari Medical NASDAQNARI

2 years ago
STZ stock news

Analyzing Analyst Recommendations and Target Price for FirstEnergy Corp.

2 years ago
Healthcare-sector

Introducing the Revolutionary Herbalife GLP1 Nutrition Companion

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Molina Healthcare: Crisis or Opportunity as Legal Storms and a Legendary Investor Collide?

Nio’s Unprecedented Delivery Streak Fuels Profitability Push

Is 3M’s Resurgence Signaling a Sustainable Recovery?

Eastman Chemical’s Challenging Quarter: A Deep Dive into the Numbers

BioNTech’s Crossroads: Navigating Losses Amid Cancer Research Promise

China Lifts Export Ban on Illumina’s DNA Sequencers, Sparking Market Rally

Trending

MannKind Stock
Analysis

MannKind Shares Surge on Exceptional Quarterly Performance

by Robert Sasse
November 6, 2025
0

MannKind Corporation witnessed a substantial rally in its share price following the release of its third-quarter 2025...

Amgen Stock

Amgen’s Impressive Quarterly Performance Fuels Investor Confidence

November 6, 2025
Teledyne Stock

An Overlooked AI Contender Emerges in Defense Technology

November 6, 2025
Molina Healthcare Stock

Molina Healthcare: Crisis or Opportunity as Legal Storms and a Legendary Investor Collide?

November 6, 2025
Nio Stock

Nio’s Unprecedented Delivery Streak Fuels Profitability Push

November 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • MannKind Shares Surge on Exceptional Quarterly Performance
  • Amgen’s Impressive Quarterly Performance Fuels Investor Confidence
  • An Overlooked AI Contender Emerges in Defense Technology

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com